NCT04991467

Brief Summary

For caregivers in the Bronx, the pandemic has caused unprecedented psychological distress; in addition to combating social determinants of health (SDOH), these families now face greater financial insecurity and challenges related to their school-aged children. Furthermore, social distancing requirements and limited telehealth resources for Bronx families have posed greater barriers to healthcare. Such parental distress contributes to heightened risk of transgenerational cycles of psychological stress, trauma and maltreatment. The social and economic impacts of the COVID-19 pandemic have had significant consequences for family well-being, putting parents at higher risk of experiencing distress and potentially impairing their ability to provide supportive care to their children. Although children may be less susceptible to the most damaging physical consequences of COVID-19, there are growing concerns regarding the short-and long-term impacts of pandemic-related stressors on children. The marked upheaval of family life over an extended period may make children vulnerable to mental health consequences associated with the public health crisis and infection mitigation efforts. School and childcare closures, unstable financial circumstances, social isolation and lack of support have a disproportionate, cumulative impact on parents and may undermine their capacities to provide support for their children. Importantly, a large body of evidence suggests that parental stress during times of disasters induces psychopathologies in family members including children. Further, high anxiety and depressive symptoms in parents during the pandemic have been associated with higher child abuse potential, whereas greater parental support was associated with lower perceived stress and child abuse potential. In addition to psychological impacts, stress associated with caregiving can interfere with parents' ability to maintain their own health. This multimodal study addresses key strategies to mitigate the psychological and health impact of COVID-19 in parents.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
360

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Dec 2021

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 16, 2021

Completed
20 days until next milestone

First Posted

Study publicly available on registry

August 5, 2021

Completed
4 months until next milestone

Study Start

First participant enrolled

December 17, 2021

Completed
4.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2026

Completed
Last Updated

September 12, 2025

Status Verified

September 1, 2025

Enrollment Period

4.4 years

First QC Date

July 16, 2021

Last Update Submit

September 8, 2025

Conditions

Keywords

COVIDParental StressSocial Determinants of HealthValera

Outcome Measures

Primary Outcomes (1)

  • Change in Caregiver Perceived Stress

    Change in Caregiver Perceived Stress will be assessed using the Perceived Stress Scale (PSS). The PSS is 10-item scale which measures the degree to which situations in one's life are appraised as stressful and serves as an assessment of overall stress. Participants provide responses on the PSS based on their perceptions of stress over the prior month. Items are scored on a 5-point Likert scale ranging from 0 ("Never") to 4 ("Very Often"), for an overall possible score of 0-40. Responses to the 4 positively worded items on the scale (Items 4, 5, 7, and 8) are reverse scored (e.g., 0=4 and 4=0). Higher overall scores are associated with greater perceived stress over the past month. For purposes of this study change from baseline will be assessed and positive scores are associated with increased perceptions of stress. Scores will be summarized by study arm using basic descriptive statistics. Paired t-tests will be used to compare parental stress vs. baseline within each arm.

    From Week 0 to Week 6, Week 12, and Week 24

Secondary Outcomes (6)

  • Change in Parental Reflective Functioning (PRF) - Children

    From Week 0 to Week 6, Week 12, and Week 24

  • Change in Parent Reflective Functioning (PRF) - Adolescent

    From Week 0 to Week 6, Week 12, and Week 24

  • Change in Access to Healthcare

    From Week 0 to Week 6, Week 12, and Week 24

  • Change in Depression

    From Week 0 to Week 6, Week 12, and Week 24

  • Change in Anxiety

    From Week 0 to Week 12, and Week 24

  • +1 more secondary outcomes

Other Outcomes (20)

  • Change in Five Minute Speech Sample

    From Week 0 to Week 6, Week 12, and Week 24

  • Change in Multidimensional Scale of Perceived Social Support

    From Week 0 to Week 24

  • Change in Youth Outcome Questionnaire

    From Week 0 to Week 24

  • +17 more other outcomes

Study Arms (3)

Parents of children receiving mental health treatment at Montefiore

EXPERIMENTAL

Participants will either CARE program alone; b) Valera Health app; c) CARE program and Valera Health app .

Behavioral: CARE Program and Valera Application with care manager functionalityBehavioral: Valera Application with care manager functionalityBehavioral: CARE Program

Parents of children being treated for autoimmune disorders at Montefiore

EXPERIMENTAL

Participants will either CARE program alone; b) Valera Health app; c) CARE program and Valera Health app.

Behavioral: CARE Program and Valera Application with care manager functionalityBehavioral: Valera Application with care manager functionalityBehavioral: CARE Program

Healthcare workers at Montefiore

EXPERIMENTAL

Participants will either CARE program alone; b) Valera Health app; c) CARE program and Valera Health app.

Behavioral: CARE ProgramBehavioral: Valera ApplicationBehavioral: CARE Program and Valera Application

Interventions

Participant will take part in 12 week CARE program and receive the Valera health application which will provide parent education materials as well as the ability to connect to their child's treatment team via care manager.

Parents of children being treated for autoimmune disorders at MontefioreParents of children receiving mental health treatment at Montefiore

Participant will receive the Valera health application which will provide parent education materials and the ability to connect to their child's treatment team via care manger.

Parents of children being treated for autoimmune disorders at MontefioreParents of children receiving mental health treatment at Montefiore
CARE ProgramBEHAVIORAL

Participant will take part in 12 week CARE program.

Healthcare workers at MontefioreParents of children being treated for autoimmune disorders at MontefioreParents of children receiving mental health treatment at Montefiore

Participant will receive the Valera health application which will provide parent education materials.

Healthcare workers at Montefiore

Participant will take part in 12 week CARE program and receive the Valera health application which will provide parent education materials.

Healthcare workers at Montefiore

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • All participants will be primary caregivers who present with moderate level of stress by meeting a severity score of ≥ 14 on the Perceived Stress Scale (PSS)
  • Investigators will allow primary caregivers (e.g., grandmothers and aunts) as it is common in the patient population
  • Clinical cohorts will be active patients in the psychiatric and rheumatology clinics in Montefiore Medical Center (MMC)
  • Frontline health care providers will be those who are required to work on site at Montefiore Medical Center (MMC)

You may not qualify if:

  • Serious psychiatric or substance use difficulty that, in the judgement of the PI, would preclude meaningful participation in a parent intervention
  • Active child abuse/maltreatment cases
  • Neurocognitive conditions that may prevent participants from accessing telehealth services
  • Primary language other than Spanish or English
  • Use of the Valera Health app or a smartphone health platform similar to the Valera app

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Montefiore Medical Center

The Bronx, New York, 10461, United States

RECRUITING

MeSH Terms

Conditions

COVID-19

Condition Hierarchy (Ancestors)

Pneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract Diseases

Study Officials

  • Jonathan Alpert, MD

    Albert Einstein College of Medicine

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
FACTORIAL
Model Details: 3 interventions: Care \& Valera, Care only, and Valera only.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 16, 2021

First Posted

August 5, 2021

Study Start

December 17, 2021

Primary Completion

May 1, 2026

Study Completion

May 1, 2026

Last Updated

September 12, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will share
Shared Documents
STUDY PROTOCOL, SAP, ICF

Locations